Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

被引：0
作者：
Chandra R Tate
Lyndsay V Rhodes
H Chris Segar
Jennifer L Driver
F Nell Pounder
Matthew E Burow
Bridgette M Collins-Burow
机构：
[1] Tulane University Health Sciences Center,Department of Medicine, Section of Hematology and Medical Oncology
来源：
Breast Cancer Research | / 14卷
关键词：
Panobinostat; LBH589; triple-negative breast cancer; xenograft; histone deacetylase inhibitor; E-cadherin; CDH1; epithelial-to-mesenchymal transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 459 条
  • [1] Jemal A(2011)Global cancer statistics CA: Cancer J Clin 61 69-90
  • [2] Bray F(2010)Novel therapeutic approaches to the treatment of metastatic breast cancer Cancer Treat Rev 36 33-42
  • [3] Center MM(2011)Treatment and care of patients with metastatic breast cancer Nurs Stand 25 49-56
  • [4] Ferlay J(2008)Triple-negative breast cancer: risk factors to potential targets Clin Cancer Res 14 8010-8018
  • [5] Ward E(2007)Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429-4434
  • [6] Forman D(2010)Triple-negative breast cancer: a short review Am J Clin Oncol 33 637-645
  • [7] Fernandez Y(2009)Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer Clin Breast Cancer 9 S73-81
  • [8] Cueva J(2011)Triple-negative breast cancer: an unmet medical need Oncologist 16 1-11
  • [9] Palomo AG(2010)Treatment of triple negative breast cancer (TNBC): current options and future perspectives Cancer Treat Rev 36 S80-86
  • [10] Ramos M(2010)Triple-negative breast cancer Breast Cancer Res 12 S3-528
12345678910